Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

FDA Drug Application 020154 by BRISTOL MYERS SQUIBB

Application Number	020154
Application Type	New Drug Application
Sponsor Applicant	BRISTOL MYERS SQUIBB
Most Recent Label Available Flag
Current Patent Flag
Action Type	Approval
Chemical Type	New molecular entity (NME)
Therapeutic Potential	Priority*
Orphan Code

Action Type	Action Date	Document Type	Application Document ID	Sequence Number	Document URL	Document Date
AP	10/9/1991	N	26151	000	http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm201885.htm	8/9/2010
AP	4/1/1992	SCS
AP	2/4/1993	SCP	17526	004	http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020154_S004_VIDEX.pdf	8/6/2007
AP	9/25/1992	SE2
AP	2/10/1994	SLR
AP	8/21/1995	SLR
AP	8/5/1994	SE1	17527	009	http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020154_S009_VIDEX.pdf	8/6/2007
AP	4/13/1994	SCS
AP	2/27/1996	SCF
AP	8/21/1995	SLR
AP	2/10/1994	SLR
AP	8/21/1995	SLR
AP	8/21/1995	SLR
AP	6/26/1996	SLR
AP	6/15/1995	SLR
AP	7/14/1995	SCS
AP	3/13/1996	SCS
AP	7/17/1996	SE1	17528	020	http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020154_S020_VIDEX.pdf	8/6/2007
AP	6/26/1996	SLR
AP	7/31/1996	SCM
AP	4/23/1998	SLR
AP	1/5/1998	SCS
AP	6/23/1998	SCS
AP	11/25/1998	SCS
AP	11/25/1998	SCS
AP	7/1/1999	SE1	10908	028	http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-154s028_20-155s020_20156s021_Videx.cfm	1/6/2005
AP	10/28/1999	SE2	2585	029	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20154S29,30LTR.PDF	10/29/1999
AP	10/28/1999	SE2	2587	029	http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20154LBL.PDF	10/29/1999
AP	10/28/1999	SE2	9963	029	http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-154s029s030_20-155s021_20-156s022_Videx.cfm	8/9/2004
AP	10/28/1999	SCF	2591	030	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20154S29,30LTR.PDF	10/29/1999
AP	10/28/1999	SCF	2592	030	http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20154LBL.PDF	10/29/1999
AP	10/28/1999	SCF	9964	030	http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-154s029s030_20-155s021_20-156s022_Videx.cfm	8/9/2004
AP	7/3/2000	SLR
AP	7/24/2000	SLR	11439	032	http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020154s032s033_020155s023s024_020156s024s025_Videx.cfm	4/19/2005
AP	7/24/2000	SE8	11440	033	http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/020154s032s033_020155s023s024_020156s024s025_Videx.cfm	4/19/2005
AP	7/27/2001	SLR
AP	9/10/2001	SLR	5397	035	http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20154s35lbl.pdf	4/21/2003
AP	11/16/2001	SLR	5398	036	http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20154s36lbl.pdf	4/21/2003
AP	4/1/2002	SE8	2566	037	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20154s037ltr.pdf	4/1/2002
AP	4/1/2002	SE8	2568	037	http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20154s37lbl.pdf	4/1/2002
AP	8/23/2002	SCS
AP	9/25/2002	SLR	2520	040	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20154slr040,041,20155slr030,031,20156slr031032ltr.pdf	9/25/2002
AP	9/25/2002	SLR	2521	040	http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20154s40,s41lbl.pdf	9/25/2002
AP	9/25/2002	SLR	11462	040	http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020154s040s041_020155s030s031_020156s031s032_Videx.cfm	4/27/2005
AP	9/25/2002	SLR	2529	041	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20154slr040,041,20155slr030,031,20156slr031032ltr.pdf	9/25/2002
AP	9/25/2002	SLR	2531	041	http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20154s40,s41lbl.pdf	9/25/2002
AP	9/25/2002	SLR	11463	041	http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020154s040s041_020155s030s031_020156s031s032_Videx.cfm	4/27/2005
AP	3/4/2003	SLR	4193	042	http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20154slr042,20156slr033,20155slr032,21183slr007videx_lbl.pdf	3/6/2003
AP	3/4/2003	SLR	4226	042	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20154slr042,20156slr033,20155slr032,21183slr007ltr.pdf	3/10/2003
AP	1/21/2004	SLR	7582	044	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20154slr044,20155slr034,20156slr035,21183slr010ltr.pdf	1/22/2004
AP	1/21/2004	SLR	7608	044	http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20154slr044,20155slr034,20156slr035,21183s010_videx_lbl.pdf	1/22/2004
AP	8/18/2006	SLR	14747	049	http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020154s49,20155s38,20156s39,21183s15lbl.pdf	8/21/2006
AP	8/18/2006	SLR	14894	049	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020154s049, 020155s038, 020156s039, 021183s015LTR .pdf	9/18/2006
AP	8/18/2006	SLR	18556	049	http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/020154_S049_VIDEX.pdf	11/19/2007
AP	11/29/2006	SLR	15414	050	http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020154s50,20155s39,20156s40,21183s16lbl.pdf	12/4/2006
AP	11/29/2006	SLR	15580	050	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020154s050, 020155s039, 020156s040, 021183s016ltr.pdf	12/28/2006

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB